J1551 HCPCS Level II code: Injection, immune globulin (cutaquig), 100 mg

J1551 is the HCPCS code for “Injection, immune globulin (cutaquig), 100 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J1551

Injection, immune globulin (cutaquig), 100 mg

Short description: Inj cutaquig 100 mg

HCPCS · United States

Medicare details

The indicators CMS publishes with J1551 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Drugs
ASC
Approved for ambulatory surgical centers
Type of service
Medical care
BETOS category
Other drugs
Added
Jul 1, 2022

Where J1551 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J1551Injection, immune globulin (cutaquig), 100 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J1551 mean?

J1551 is the HCPCS code for “Injection, immune globulin (cutaquig), 100 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J1551?

CMS lists J1551’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.